GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cytokinetics Inc (FRA:KK3A) » Definitions » Pre-Tax Income

Cytokinetics (FRA:KK3A) Pre-Tax Income : €-490.33 Mil (TTM As of Mar. 2024)


View and export this data going back to 2004. Start your Free Trial

What is Cytokinetics Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Cytokinetics's pretax income for the three months ended in Mar. 2024 was €-124.79 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was €-490.33 Mil. Cytokinetics's pretax margin was -16,248.96%.

During the past 13 years, Cytokinetics's highest Pretax Margin was 15.46%. The lowest was -14141.74%. And the median was -321.57%.


Cytokinetics Pre-Tax Income Historical Data

The historical data trend for Cytokinetics's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cytokinetics Pre-Tax Income Chart

Cytokinetics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -109.52 -104.63 -190.55 -367.17 -482.57

Cytokinetics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -122.62 -118.73 -121.27 -125.53 -124.79

Competitive Comparison of Cytokinetics's Pre-Tax Income

For the Biotechnology subindustry, Cytokinetics's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cytokinetics's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cytokinetics's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Cytokinetics's Pre-Tax Income falls into.



Cytokinetics Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Cytokinetics's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-455.02+0+-52.882+25.336+0
=-482.57

Cytokinetics's Pretax Income for the quarter that ended in Mar. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-116.136+0+-15.935+7.28+-0.0010000000000048
=-124.79

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-490.33 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cytokinetics  (FRA:KK3A) Pre-Tax Income Explanation

Cytokinetics's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=-124.792/0.768
=-16,248.96%

During the past 13 years, Cytokinetics's highest Pretax Margin was 15.46%. The lowest was -14141.74%. And the median was -321.57%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cytokinetics Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Cytokinetics's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Cytokinetics (FRA:KK3A) Business Description

Traded in Other Exchanges
Address
350 Oyster Point Boulevard, South San Francisco, CA, USA, 94080
Cytokinetics Inc is a biotechnology company that develops muscle biology-driven treatments for diseases characterized by reduced muscle function, muscle weakness, and fatigue. The company develops treatments for diseases such as amyotrophic lateral sclerosis, heart failure, spinal muscular atrophy, and chronic obstructive pulmonary disease. The treatment is based on small molecules specifically engineered to increase muscle function and contractility. The company is developing muscle-directed investigational medicines that may potentially improve the health span of people with devastating cardiovascular and neuromuscular diseases of impaired muscle function.

Cytokinetics (FRA:KK3A) Headlines

No Headlines